Fracture-related infection blood-based biomarkers: Diagnostic strategies.

Injury · Nov 2024 · Review

Natoli RM, Malek S

Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University

Orthopaedic Trauma

SUMMARY — THE REDUCTIONThis review of blood-based biomarkers for fracture-related infection highlights current diagnostic limitations and the promise of emerging omics-based approaches for earlier detection.
Abstract, as published

Fracture-related infections are significant postoperative complications that carry substantial patient burden and additional healthcare costs. Despite their impact on outcome, early diagnosis of these infections remains challenging due to current available tests lacking acceptable diagnostic parameters. This review compiles existing information on blood-based biomarkers that have been evaluated as early diagnostic tools and highlights the challenges in their reliability. To begin to overcome these challenges new avenues of biomarker discovery utilizing "omics" technologies and novel analytical methods are being investigated in recent years. It appears that, despite their complexity, these newer approaches may be the future in biomarker discovery for fracture-related infection diagnosis.

Featured in the 2026-09-02 issue.

← Secondary Fracture Prevention: Consensus Clinical Recommendat…Sacral Insufficiency Fractures: Pathology, Management, and Ou… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.